Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 PCSK9 Inhibitors for Statin Intolerance?

Literature DB >> 27039138

PCSK9 Inhibitors for Statin Intolerance?

David D Waters¹, Priscilla Y Hsue¹, Sripal Bangalore².

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2016 PMID： 27039138 PMCID： PMC5761646 DOI： 10.1001/jama.2016.3670

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

× No keyword cloud information.

16 in total

Review 1. Statin-Associated Autoimmune Myopathy.

Authors: Andrew L Mammen
Journal: N Engl J Med Date: 2016-02-18 Impact factor: 91.245

2. Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update.

Authors: G B John Mancini; A Yashar Tashakkor; Steven Baker; Jean Bergeron; David Fitchett; Jiri Frohlich; Jacques Genest; Milan Gupta; Robert A Hegele; Dominic S Ng; Glen J Pearson; Janet Pope
Journal: Can J Cardiol Date: 2013-09-29 Impact factor: 5.223

3. The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K.

Authors: Peter S Sever; Choon L Chang; Ajay K Gupta; Andrew Whitehouse; Neil R Poulter
Journal: Eur Heart J Date: 2011-08-28 Impact factor: 29.983

4. Identification and management of patients with statin-associated symptoms in clinical practice: A clinician survey.

Authors: G Kees Hovingh; Shravanthi R Gandra; Jan McKendrick; Ricardo Dent; Heather Wieffer; Alberico L Catapano; Paul Oh; Robert S Rosenson; Erik S Stroes
Journal: Atherosclerosis Date: 2015-12-11 Impact factor: 5.162

5. Discontinuation of statins in routine care settings: a cohort study.

Authors: Huabing Zhang; Jorge Plutzky; Stephen Skentzos; Fritha Morrison; Perry Mar; Maria Shubina; Alexander Turchin
Journal: Ann Intern Med Date: 2013-04-02 Impact factor: 25.391

6. An assessment by the Statin Muscle Safety Task Force: 2014 update.

Authors: Robert S Rosenson; Steven K Baker; Terry A Jacobson; Stephen L Kopecky; Beth A Parker
Journal: J Clin Lipidol Date: 2014 May-Jun Impact factor: 4.766

7. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)

Authors: P Jones; S Kafonek; I Laurora; D Hunninghake
Journal: Am J Cardiol Date: 1998-03-01 Impact factor: 2.778

8. Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.

Authors: Steven E Nissen; Erik Stroes; Ricardo E Dent-Acosta; Robert S Rosenson; Sam J Lehman; Naveed Sattar; David Preiss; Eric Bruckert; Richard Ceška; Norman Lepor; Christie M Ballantyne; Ioanna Gouni-Berthold; Mary Elliott; Danielle M Brennan; Scott M Wasserman; Ransi Somaratne; Rob Scott; Evan A Stein
Journal: JAMA Date: 2016-04-19 Impact factor: 56.272

9. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Authors: C Baigent; L Blackwell; J Emberson; L E Holland; C Reith; N Bhala; R Peto; E H Barnes; A Keech; J Simes; R Collins
Journal: Lancet Date: 2010-11-08 Impact factor: 79.321

10. Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy: 20-Year Follow-Up of West of Scotland Coronary Prevention Study.

Authors: Ian Ford; Heather Murray; Colin McCowan; Chris J Packard
Journal: Circulation Date: 2016-02-10 Impact factor: 29.690

4 in total

Review 1. PCSK9 Antibody-based Treatment Strategies for Patients With Statin Intolerance.

Authors: Errika Voutyritsa; Christos Damaskos; Paraskevi Farmaki; Georgios Kyriakos; Evangelos Diamantis; Lourdes Victoria Quiles-SÁnchez; Anna Garmpi; Nikolaos Garmpis; Alexandros Patsouras; Athanasia Stelianidi; Spyridon Savvanis
Journal: In Vivo Date: 2021 Jan-Feb Impact factor: 2.155